Cialis Market Share
Cialis did a good job since its launch and their sales were going up; starting with $250 million and in 6 years taking it beyond the mark of $1 billion; plus its rating at the stocks were positive but due to global economic crunch and some issues between the two partners who developed Cialis, Eli Lilly and Icos Corp, it ended with Eli Lilly buying it for $2.3 billion.
Cialis poses a continuous threat to the Viagra’s monopoly specially in the international market with 35.5% of the ex-US market, was on track to become the No. 1 global ED drug in 2007. Viagra leads outside the US, with 49.3% of the market, while Levitra boasts 15.3% share.
Viagra held a stronger lead in the US, with 56.6% total market share and sales of $615 million for the first nine months of 2006, but sales were down 6%. Cialis held 27% of the US market, with sales up 26% to $294 million, while Levitra claimed 13.3% with sales up 30% to $144 million.
In France Cialis is the largest market share holder and in US they are gradually but steadily earning its ground by primarily targeting 40 plus male and that is the reason behind the increase of their sales.